Navigation Links
Human Genome Sciences Presents Results of Phase 2 Trial of Albuferon(R) in Chronic Hepatitis C Patients Who Failed To Respond To Previous Therapy
Date:11/5/2007

- Results demonstrated 17% overall rate of sustained virologic response in

non-responders to previous interferon-based therapy - - SVR results in line with previous studies of long-acting interferons in

non- responders, with less frequent dosing - - Final data from Phase 2 Albuferon non-responder study presented at the Annual Meeting of the American Association for the Study of Liver Diseases

(AASLD) -

ROCKVILLE, Ma., Nov. 5 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced the final results of a Phase 2 trial of the investigational drug, Albuferon(R) (albinterferon alfa-2b), in combination with ribavirin in patients with chronic hepatitis C who failed to respond to previous interferon-based therapy. The results were presented yesterday in Boston at the 58th AASLD Annual Meeting in Boston.

(Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO )

"The results of the Albuferon non-responder study demonstrated that Albuferon treatment at doses up to 1800 mcg every two weeks had an acceptable long-term safety profile and produced an overall sustained virologic response (SVR) rate of 17% in these patients," said David Nelson, M.D., Associate Professor of Medicine, Medical Director of Liver Transplantation, and Chief of the Hepatobiliary Disease Section, University of Florida. "In the difficult to treat subgroup of genotype 1 chronic hepatitis C patients who previously failed to respond to treatment with pegylated interferon and ribavirin, Albuferon treatment produced an overall SVR rate of 11%."

In the open-label,
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Video: New Research Discovers Independent Brain Networks Control Human Walking
2. Lpath Demonstrates Strong Safety Profile of Lead Drug Candidate, Sphingomab(TM), in Non-Human Primates
3. Enrollment Begins on Human PK Study for Medidur(TM) FA
4. Human Genome Sciences Completes Enrollment of First Phase 3 Albuferon(R) Trial Ahead of Schedule
5. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
6. Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process
7. Peregrine Researchers Report Data Showing Bavituximabs Potential to Shrink Human Prostate Tumors in Model of Relapsed Disease
8. Dr. Roger Kenneth Hershline PhD MD, CEO of Global Humanceuticals, Inc. Donates New HIV Drug
9. Study Shows Plasma-Derived Human Thrombin Equivalent to Bovine Thrombin in Achieving Hemostasis in Surgery
10. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
11. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... JACKSONVILLE, Fla. , Aug. 28, 2015  With ... reaching deadlier heights, Jacksonville ... Philip Hemphill is helping to explain why ... Fentanyl is approximately 40 to 50 times more potent ... by recreational users as heroin, the risk of death ...
(Date:8/28/2015)... 28, 2015 According to a ... (Breast, Lung, Prostate) Type (Protein & Genetic Biomarkers) Profiling ... Prognostic) & Geography - Global Forecast to 2020", published ... reach around 17,689.0 Million USD by 2020 at a ... to 2020. Browse 191 Tables and ...
(Date:8/28/2015)... , Aug. 28, 2015 ... announced the addition of the "12th Annual ... Production" report to their offering. ... Biopharmaceutical Manufacturing Capacity and Production is the most ... organizations, current and projected future capacity and production. ...
Breaking Medicine Technology:Lakeview Health's Dr. Philip Hemphill Explains Why Heroin Addicts Are Now Dying of Fentanyl Overdoses 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 2Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 3Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 4Cancer Biomarkers Market Worth 17,689.0 Million USD by 2020 512th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2
... the 12th consecutive year, Henry Schein, Inc. (Nasdaq: ... products and services to office-based practitioners, brightened the holiday ... through the Company,s Holiday Cheer For Children program.  Founded ... flagship initiative of the Company,s global corporate social responsibility ...
... 2010 Amgen (Nasdaq: AMGN ) today ... first new treatment for advanced cancer patients with bone ... to Zometa® (zoledronic acid). These results underscore the efficacy ... patients with bone metastases from advanced breast cancer, as ...
Cached Medicine Technology:Henry Schein's 12th Annual Holiday Cheer For Children Program Encourages Volunteerism and Giving Among Team Schein Members 2Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 2Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 3Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 4Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 5Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 6Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 7Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 8Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 9Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 10Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 11Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 12Amgen Presents New XGEVA™ (Denosumab) Breast Cancer Skeletal-Related Event Prevention Data at SABCS 13
(Date:8/30/2015)... Raton, Fl (PRWEB) , ... August 30, 2015 , ... ... InHealth Media. Nutritional Products International and InHealth media is a global sales and ... , “We are extremely pleased to continue our business relationship with Mr. Reid Eckert, ...
(Date:8/29/2015)... ... 2015 , ... Rio Salado College President Chris Bustamante announced on ... of Strategic Initiatives and Information Services. O’Shea, who has served Rio Salado for the ... and impact through innovative technologies and strategies. , “I am very proud to be ...
(Date:8/29/2015)... PA (PRWEB) , ... August 29, 2015 , ... ... said one of two inventors from Miller Place, N.Y. "I specialize in manual ... and discomfort. In addition, it can be used for additional muscle dysfunction throughout ...
(Date:8/29/2015)... ... August 29, 2015 , ... Brands like Toppik ... zero standard shipping costs. , “Before, a threshold of $49.00 was required to qualify ... and items qualify for free standard shipping for customers regardless of the item’s selling ...
(Date:8/29/2015)... ... August 29, 2015 , ... Hamstring ... area with stretching, soft tissue manipulation. Platelet rich plasma injections also have ... research to improve treatment outcomes. This localized treatment seems to address the ...
Breaking Medicine News(10 mins):Health News:Nutrition Guru Continues Relationship With Renowned Health and Wellness Company 2Health News:Rio Salado College Appoints New Vice President of Strategic Initiatives and Information Services 2Health News:Inventors and InventHelp Clients Develops Tension Reliever (LGI-1951) 2Health News:TheBeautyPlace.com Discounts Shipping on Select Brands 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 2Health News:NEW APPROACH for Treatment of Recurrent Hamstring Strains and Hamstring Tendinosis is Available for the First Time in NYC 3
... The e-marketing ebook, ... find the right ways to embrace this new communication environment and lead the drive in ... (PRWEB) ... After a devastating recession in 2009, this year has been a time of painful ...
... The free ... book entitled God,s New Law, which describes a prophecy from the year 2000 that forgives homosexuality ... of gay marriage in God,s kingdom. , ... San Diego, CA (PRWEB) February 18, 2010 -- This is a new version of the ...
... ... ... -- Abatement Technologies has announced the availability of the new high performance RAPTOR Centrifugal ... (25 lbs.) RAPTOR Centrifugal Air Movers create high-speed 2,850 fpm airflow and draw less than ...
... ... blocked all of its ocean freight import records from the public. Meanwhile, Microsoft, Google ... and online marketers. , ... Washington D.C. (PRWEB) February 17, 2010 -- Trade Privacy LLC , a ...
... ... Oridion Systems Ltd. (SIX Swiss Exchange: ORIDN) the ... as the recipient of the North American “2010 Customer Value Enhancement ... Award recognizes Oridion’s focus on enhancing the value it delivers to ...
... Feb. 17 The Minnesota Chiropractic Association (MCA) ... suit against the Blue Cross Blue Shield Association ("BCBSA") and ... the Defendants, abusive practices in using post-payment audits and reviews, ... sums that have previously properly been paid as health insurance ...
Cached Medicine News:Health News:Your e-Marketing Journey in 2010: An e-Book for Corporate Communicators Working in European Headquarters 2Health News:Lo Cest Offers a Free Download of a New Bible for the Gay Community 2Health News:Abatement Technologies Announces High-Velocity RAPTOR™ Air Movers for Water Damage Restoration Contractors 2Health News:Trade Privacy LLC: Research Concludes Apple Inc. Has Blocked Their Import Records from Public Access 2Health News:Oridion Receives Frost & Sullivan's 2010 Customer Value Enhancement Award 2Health News:Oridion Receives Frost & Sullivan's 2010 Customer Value Enhancement Award 3Health News:Oridion Receives Frost & Sullivan's 2010 Customer Value Enhancement Award 4Health News:Oridion Receives Frost & Sullivan's 2010 Customer Value Enhancement Award 5Health News:Minnesota Chiropractic Association Supports Lawsuit Against BCBSA 2Health News:Minnesota Chiropractic Association Supports Lawsuit Against BCBSA 3
... long been a standard requirement ... used during laser procedures, however, ... contend that smoke plume generated ... harmful as smoke plume generated ...
Dornier Holmium Laser for Urological Procedures...
imEXPRESS uses the control panel and setup wizard concept (familiar to any Windows user) allowing you to quickly and easily connect and control your instruments....
... Hue test studies the characteristic axies ... D15, however this 28 hue test ... sensitivity. Case comes with a transparent ... Kit includes laminated scoring template (approx ...
Medicine Products: